Replies to post #163959 on Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

Dose optimizations are what P2 is for, which K is about to start. That's just the way it is.

Seems that can't be emphasized enough today as there seems to be a complete misunderstanding of trial phase purposes and the data required to include elements to move from purely safety (for example phase 1a focused entirely on toxicity in a multi-phase 1 trial set).